Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Jay Richards, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Bates College, Lewiston, MEBS06/2005Chemistry
Harvard Medical School, Boston, MAMD05/2011Medicine
Beth Israel Deaconess Medical Center, Boston, MA06/2014Internal Medicine
Massachusetts General Hospital, Boston, MA06/2018Pulmonary and Critical Care Medicine
2018 - 2021
Program for Adult Care Excellence
2016 - 2018
Fellow
2015
Phi Beta Kappa
2015
Sigma Xi

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. RICHAR16B0 (Christopher Richards) Jul 1, 2016 - Jun 30, 2018
    Cystic Fibrosis Foundation

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mojica JE, Richards CJ, Husseini JS, Hariri LP. Case 40-2018: A 47-Year-Old Woman with Recurrent Sinusitis, Cough, and Bronchiectasis. N Engl J Med. 2018 Dec 27; 379(26):2558-2565. PMID: 30586519.
    Citations:    Fields:    Translation:HumansCells
  2. Richards CJ, Mukamal KJ, DeMelo N, Smith CC. Fourth-Year Medical School Course Load and Success as a Medical Intern. J Grad Med Educ. 2017 Feb; 9(1):58-63. PMID: 28261395.
    Citations:    Fields:    Translation:Humans
  3. Richards CJ, Hsu D, Weinstock TG, Clardy P. Eosinophils. An unexpected delivery. Ann Am Thorac Soc. 2013 Aug; 10(4):390-2. PMID: 23952864.
    Citations: 2     Fields:    Translation:Humans
  4. Je Y, Sonpavde G, Galsky MD, Nguyen PL, Schutz F, Heng DY, Richards CJ, Choueiri TK. Incidence and risk of infections in renal cell cancer (RCC) and non-RCC patients treated with everolimus and temsirolimus: A meta-analysis of randomized control trials. J Clin Oncol. 2013 Feb 20; 31(6_suppl):353. PMID: 28136852.
    Citations:    
  5. Je Y, Sonpavde G, Galsky MD, Kaymakcalan M, Nguyen PL, Schutz F, Heng DY, Richards CJ. Incidence and risk of treatment-related mortality in patients with renal cell cancer (RCC) and non-RCC treated with mammalian target of rapamycin (mTOR) inhibitors. J Clin Oncol. 2013 Feb 20; 31(6_suppl):347. PMID: 28136993.
    Citations:    
  6. Richards CJ, Je Y, Schutz FA, Choueiri TK. Meta-analysis of randomized control trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors. J Clin Oncol. 2012 Feb 10; 30(5_suppl):349. PMID: 28143053.
    Citations:    
  7. Schutz FA, Je Y, Richards CJ, Choueiri TK. Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors. J Clin Oncol. 2012 Mar 10; 30(8):871-7. PMID: 22312105.
    Citations: 38     Fields:    Translation:Humans
  8. Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, Choueiri TK. Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib. J Clin Oncol. 2011 Sep 01; 29(25):3450-6. PMID: 21810682.
    Citations: 42     Fields:    Translation:Humans
  9. Richards C, Pantanowitz L, Dezube BJ. Antimicrobial and non-antimicrobial tetracyclines in human cancer trials. Pharmacol Res. 2011 Feb; 63(2):151-6. PMID: 20951804.
    Citations: 10     Fields:    Translation:Humans
  10. Tao W, Richards C, Hamer D. Enhancement of HIV infection by cellulose sulfate. AIDS Res Hum Retroviruses. 2008 Jul; 24(7):925-9. PMID: 18627218.
    Citations: 32     Fields:    Translation:HumansCells
  11. Dignam CF, Zopf JJ, Richards CJ, Wenzel TJ. Water-soluble calix[4]resorcarenes as enantioselective NMR shift reagents for aromatic compounds. J Org Chem. 2005 Sep 30; 70(20):8071-8. PMID: 16277329.
    Citations: 1     Fields:    Translation:Cells
  12. Dignam CF, Richards CJ, Zopf JJ, Wacker LS, Wenzel TJ. An enantioselective NMR shift reagent for cationic aromatics. Org Lett. 2005 Apr 28; 7(9):1773-6. PMID: 15844903.
    Citations:    Fields:    Translation:Cells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Richards's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.